GSA Capital Partners LLP lifted its position in shares of Stericycle Inc (NASDAQ:SRCL) by 63.7% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,433 shares of the business services provider’s stock after buying an additional 2,893 shares during the quarter. GSA Capital Partners LLP’s holdings in Stericycle were worth $485,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Federated Investors Inc. PA increased its holdings in Stericycle by 129.5% in the 1st quarter. Federated Investors Inc. PA now owns 2,088 shares of the business services provider’s stock valued at $122,000 after acquiring an additional 1,178 shares during the last quarter. Whittier Trust Co. increased its holdings in Stericycle by 362.6% in the 2nd quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock valued at $129,000 after acquiring an additional 852 shares during the last quarter. Dupont Capital Management Corp increased its holdings in Stericycle by 102.2% in the 2nd quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock valued at $136,000 after acquiring an additional 1,056 shares during the last quarter. Intact Investment Management Inc. bought a new stake in Stericycle in the 2nd quarter valued at $202,000. Finally, Diversified Trust Co bought a new stake in Stericycle in the 2nd quarter valued at $220,000. Institutional investors own 95.46% of the company’s stock.

In other news, CFO Daniel Ginnetti sold 5,000 shares of the business’s stock in a transaction dated Wednesday, August 1st. The shares were sold at an average price of $70.00, for a total value of $350,000.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Mark C. Miller sold 95,227 shares of the business’s stock in a transaction dated Monday, July 2nd. The stock was sold at an average price of $65.05, for a total transaction of $6,194,516.35. Following the completion of the sale, the director now owns 257,488 shares in the company, valued at $16,749,594.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 170,601 shares of company stock worth $11,153,063. Insiders own 3.50% of the company’s stock.

Stericycle stock opened at $61.69 on Tuesday. Stericycle Inc has a twelve month low of $56.64 and a twelve month high of $76.73. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.81 and a current ratio of 0.81. The stock has a market capitalization of $5.26 billion, a PE ratio of 14.21, a price-to-earnings-growth ratio of 1.42 and a beta of 0.36.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, August 2nd. The business services provider reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of $1.13 by $0.04. Stericycle had a net margin of 5.03% and a return on equity of 14.04%. The firm had revenue of $883.30 million for the quarter, compared to the consensus estimate of $896.62 million. During the same period in the previous year, the firm posted $1.15 EPS. The business’s quarterly revenue was down 3.7% on a year-over-year basis. equities analysts forecast that Stericycle Inc will post 4.47 earnings per share for the current fiscal year.

SRCL has been the topic of a number of research reports. Zacks Investment Research upgraded shares of Stericycle from a “hold” rating to a “buy” rating and set a $73.00 price target on the stock in a report on Friday, July 6th. BidaskClub downgraded shares of Stericycle from a “strong-buy” rating to a “buy” rating in a report on Friday. BMO Capital Markets reduced their price target on shares of Stericycle from $71.00 to $63.00 and set a “market perform” rating on the stock in a report on Monday, August 6th. Jefferies Financial Group set a $75.00 price target on shares of Stericycle and gave the company a “buy” rating in a report on Thursday, August 2nd. Finally, Barrington Research reiterated a “buy” rating on shares of Stericycle in a report on Friday, June 1st. Two research analysts have rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $71.71.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Featured Story: Hedge Funds

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.